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Abstract 
Introduction: The impact of HIV on the one-month perioperative morbidity and mortality 
in patients undergoing cardiac surgery in sub-Saharan Africa (SSA) in the Anti-
Retroviral Therapy (ART) era is not known. Pre ART era data from South Africa 
suggested that patients with a CD4 count less than 400 should be selected with caution. 
European and North American information suggest that short and long-term outcomes 
of cardiac surgery in patients with HIV on ART are acceptable, but this experience 
cannot be generalized to the SSA where demographic profiles, co-morbidities and 
underlying cardiac pathology requiring surgery is significantly different. 
Methods: We set out to conduct a retrospective review of the Groote Schuur Hospital 
and Chris Barnard Division of Cardiothoracic Surgery patient records between 2003 and 
2013, to evaluate the perioperative and one month outcomes of HIV positive patients 
undergoing cardiac surgery at our tertiary care institution. Eighty-one patients met all 
our study inclusion criteria.  
Findings: The patient cohort were young, (mean age 34), female (73%) and 
predominantly black (83%), 41% were on ART, 28% had previous tuberculosis and the 
average CD4 count was 426.5 cells/μL. Of the 81 patients 54 (67%) underwent valve 
surgery, 5 (6%) underwent CABG and 3 (4%) had both. Five (6%) patients died in 
hospital prior to discharge. Bleeding requiring transfusion was the most common 
complication (n=14; 17.3%) with 2 (2.5%) requiring relook. Other complications included 
wound sepsis in 9 (11%), complete heart block in 5 (6%), acute kidney injury in 4 (5%), 
hospital-acquired pneumonia in 3 (4%), cardiac tamponade in 3 (4%) and only one (1%) 
needlestick injury was reported. The predictors of death included the need for aortic root 
replacement and prolonged cardiopulmonary bypass time (OR 25 [p=0.006] and OR 
1.02 [p= 0.01] respectively)  
Conclusion: HIV positive patients had cardiac surgical outcomes with low mortality 
rates comparable to international trends which were independent of CD4 counts. 
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SECTION A: Literature Review 
 
Objectives 
The objectives of the literature review were to appraise published literature in order to: 
• Review the historic and current outcomes of HIV positive patients undergoing 
cardiac surgery 
• Review literature in sub-Saharan Africa on the outcomes of HIV positive patients 
undergoing cardiac surgery 
• Review the impact of HIV on outcomes of patients undergoing cardiac surgery 
 
Search strategy 
We used several databases including PubMed/MEDLINE, Scopus and Google Scholar 
to find articles in this topic which have been published. These databases are fully 
available through the University of Cape Town online library support. The search terms 
used included ‘cardiac surgery and HIV’, ‘HIV cardiac surgery and outcomes’, ‘valve 
surgery and HIV’, ‘Coronary artery bypass graft and HIV’. The results were not limited to 
any time period but predominantly articles from 1990’s to 2014 were found. There was 
no limitation to studies from any particular continent. Only studies published in the 
English language were reviewed. Upon reading the article, the references used by the 
publication itself were studied and similar articles searched for using the publication title. 
The articles would then be imported to Endnote X9.2 referencing manager which would 
then be used as a citation manager. 
 
Ten studies were found looking at valve and/or coronary artery bypass grafting in the 
HIV positive population. One study which was not included reviewed heart 
transplantation in HIV positive patients. Several supporting articles were found with 
subsequent reading. These included topics around antiretroviral therapy (ART) and 
coronary artery disease, prevalence of HIV in South Africa, prevalence and burdens of 






A South African National HIV survey in 2012 estimated that 6.4 million (12.2%) people 
were HIV positive, an increase from 5.2 million (10.6%) in 2008. This epidemiological 
curve shift  was presumed to be a result of the effects of increased ART coverage.1 This 
has led to HIV becoming a chronic disease with almost a normal life expectancy. HIV 
positive patients are presenting more often for cardiac surgery for disease related to the 
HIV itself and treatment thereof and to traditional cardiac disease unrelated to HIV.2, 3 
Sub-Saharan Africa (SSA) has a high burden of RHD with more patients operated for 
valve replacement surgery including those with infective endocarditis.  
 
HIV itself is a risk factor for development of acute coronary syndromes through 
endothelial dysfunction, heightened pro-inflammatory state, dyslipidemia and 
thrombosis; all these events related to chronic immune activation prior to ART 
initiation.4, 5 Although ART reduces viral replication, immune activation, and markers of 
coagulation, these indices do not normalize and patients are still at risk of arterial 
thrombosis.6 Furthermore, protease inhibitors (PI) have a potential to cause metabolic 
disturbances including insulin resistance, dyslipidaemia therefore contributing to 
development of coronary artery disease alongside or in the absence of traditional risk 
factors. On the other hand, relationship of non-nucleoside reverse transcriptase 
inhibitors (NNRTI) and risk myocardial infarction has been accounted to combination 
therapy with PI rather than NNRTI having independent significant effect. All these 
relationships are time dependent, the longer the duration of ART use, the higher the 
risk.  
 
Current trends in cardiac surgery  
 
One of the earliest studies done in the research of outcomes of HIV positive patients 
undergoing cardiac surgery was by Trachoitis et al.7 This was a small sample of 37 
patients with mean age 41, most patients were on ART at the time of the surgery with 
preserved CD4 T lymphocytes (CD4 count) and no acquired immunodeficiency 
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syndrome (AIDS) defining opportunistic infections. In this study, a larger group of 27 
patients, mean age 43 had coronary artery bypass graft (CABG) while the other 10 
patients, mean age 38 had valve surgery. The group that underwent valve surgery were 
mostly fit young patients who were drug users presenting with bacterial endocarditis, 
only one early death was reported due to sepsis in the valve group. This study 
highlights the trend that more HIV positive in stable chronic disease are presenting 
more for revascularization than valve surgery as a result of bacterial endocarditis.  
 
Subsequent follow-up showed that 81% were free from angina or failure symptoms, 
myocardial infarction, death and repeat revascularization; this is inclusive of both the 
CABG and the valve patients. This data is encouraging on the long term outcome and 
low early mortality rates in this population. In a setting like South Africa where there’s a 
high burden of RHD, valve surgery is still a common indication for surgery in this 
population group.  
 
However, Mestres et al did a review of younger patients mean age 34 who had 
undergone cardiac surgery with 80% of patients being drug addicts and majority 
presenting as a result of acute infective endocarditis (IE) with an early mortality rate of 
23%.8 This mortality was associated with emergency operations as a result of unstable 
clinical status.  
 
In contrast, Chong et al had no early hospital mortality for the in their review of 22 
patients who underwent valve surgery for bacterial endocarditis.9 These were younger 
patients in good physical status with no other comorbidities. There was however poor 
long-term outcome which was mostly related to continued intravenous drug addiction 
with resultant recurrence of bacterial endocarditis with new organism.  







Table 1: Selected studies to date 
 
 
Like all forms of surgery, major risk factors that are associated with poor outcomes 
include comorbidities such as renal failure, diabetes mellitus and hypertension, 
advanced AIDS and generally unwell clinical status at the time of surgery such as with 
the case of active endocarditis. Table 2 shows risk factors for mortality and 
complications. HIV itself does not seem to be independently associated with poor 
outcomes or operative mortality.10  
 
In all these studies, patients that presented for CABG have consistently shown low to 
absent early mortality in contrast to valve surgery. These patients are generally on ART 
with stable HIV disease at the time of surgery with good CD4 counts and operated 
electively. These patients developed coronary artery disease as a result of treatment 
with ART. 


























Mestres 34 31 5 26 - 23 19 65 42  
1990-
1999 
Chong 38 22 - 22  0 14   40 
1994-
2000 
Trachoitis 41 37 27 8 2 2.7 38 81   
1995-
2003 
Blyth 33 49 3 45  6 35 - - - 
1997-
2005 
Boccara 47vs50 27vs54 27vs54 0 - 0   41  
1998-
2004 
Filsoufi 47 25 7 13 2 4 20 92 86 - 
1998-
2006 
Castillo 49 39 12 17 5 5 25 91 86 81 
2004- 
2007 
Nel 32 17 - 6 - 0  83   
1998-
2009 








Table 2: Predictors of mortality and complications 
Major comorbidity 
• Renal failure 
• Diabetes Mellitus 
• Hypertension 
Single or double valve surgery 




Co-infection with hepatitis B/C 
 
We have seen two studies examining large numbers of HIV positive patients who 
underwent cardiac surgery through data collection using the Nationwide Inpatient 
Sample (NIS) database.10, 11 In these studies, HIV was not associated with increased 
mortality; however, the risk for mortality by CD4 count was not assessed due to 
unavailability on the NIS database of CD4 counts. If we look at their sub-analysis of 
mortality and complications, we can use this as proxy for the CD4 count nadir in these 
patients as follows. When HIV positive patients were stratified according to the 
presence or absence of Acquired Immunodeficiency Syndrome (AIDS) related 
conditions, those patients with AIDS-related conditions had increased mortality compare 
to those without (OR 2.4 95% CI 1.5-3.8 vs OR 1.2 95% CI 0.8-1.8).10 In addition, HIV 
positive patients had 16% more increased overall complication risk (OR 1.16 95% CI 
1.01-1.34) particularly requirement for blood transfusion.11 This subgroup of patients 




There were no follow-up of patients to determine short or long-term outcomes. In 
addition, the dependence on coding of by non-medical personnel may have played a 
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role in over or underestimating certain figures by allocation of diagnoses to incorrect 
codes.  
 
There have been major gains in the medical care of HIV positive patients since the 
introduction of ART. There have also been major advances in perioperative 
management of these patients while there is a downward trend of patients operated 
presenting with IE. All these factors have contributed in improvement in operative 
mortality in HIV positive patients.12, 13 
CABG is becoming the most common cardiac surgery performed in HIV positive in 
industrialized countries like the United States. Prior to ART, HIV positive patients were 
rarely addressed to coronary revascularization because of the limited life expectancy.2 
All the studies to date have seen increasing number of patients for coronary 
revascularization throughout their study periods; there has been excellent outcomes in 
the long-term in the range of over 80% survival at 3 years. The operative mortality is 
decreasing with more elective, isolated coronary surgery rather than valve surgery. 
 
Valve surgery in HIV positive patients has historically been associated with IE. 
However, there is a decreasing trend in the number of patients operated for this 
indication in industrialized countries. These patients have traditionally had high early 
mortality rates with only one study showing good outcome with no early mortality.9 
However, we’ve seen a decrease in the number of patients being operated for IE 
contributing to reduced early mortality of this patient group over the past decade. 
 
Studies of cardiac surgery in sub-Saharan Africa 
 
There is paucity of research in this topic in SSA with only 3 studies focusing on this 
population outcomes following cardiac surgery. Blyth et al reviewed 49 patients, 
average age 33, undergoing various cardiac procedures including CABG, valve 
replacement, repair of congenital lesions and aortic root surgery.14 Their criteria for 
patient entry into surgery was initially good clinical status and subsequently CD4 count 
above 400 cells/μL. This lead to the average CD4 count in their cohort at 685 cells/ μL. 
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They reported 6% and 34.7% 30-day mortality and complication rate respectively. 
Subsequently, Nel et al prospectively studied a cohort of 77 patients with infective 
endocarditis, with a subset of 17 patients in their cohort HIV positive.15 The mean age 
and CD4 count was 30 years and 189 cells/μL respectively. In this study, the morbidity 
of HIV infected and uninfected patients were similar as were the mortality rate of 23.6% 
for HIV infected and 23.3% for HIV uninfected patients. Mutyaba et al focusing on 
pericardial surgery on the largest cohort of 121 showed that perioperative mortality was 
not influenced by HIV status but New York Heart Association Class IV and 
hyponatraemia predicted early mortality after pericardiectomy.16  
 
In summary, the current literature evidence suggests that HIV does not increase the risk 
of peri cardiac surgery mortality, and that the outcomes of HIV positive patients 
undergoing cardiac surgery have improved over the years. CABG is the most commonly 
performed procedure followed by valve surgery in industrialized countries. Patients with 
a history of AIDS defining illnesses may be at increased perioperative risk, as are those 
with renal failure, and anaemia-the latter variables increase risk independent of HIV 
status.  It is still unclear if CD4 count is associated with increased mortality from these 
studies. Data from Sub-Saharan Africa despite small numbers, is supportive of 
international trends that mortality of HIV positive patients undergoing cardiac surgery is 
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Introduction: Impact of HIV on the one-month perioperative morbidity and mortality in 
patients undergoing cardiac surgery in Sub-Saharan Africa in the ART era is not known.  
Methods: We conducted a retrospective review of the Groote Schuur Hospital patient 
records between 2003 and 2013. Eighty-one patients met all our study inclusion criteria.  
Findings: Mean age was 34, female (73%) and 41% were on ART, 28% had previous 
tuberculosis and the average CD4 count was 426.5 cells/μL. 54 (67%) underwent valve 
surgery, 5 (6%) underwent CABG and 3 (4%) had both. 5 (6%) patients died in hospital; 
the 30-day complication was 23%.  The predictors of death included the need for aortic 
root replacement and prolonged cardiopulmonary bypass time (OR 25 [p=0.006] and 
OR 1.02 [p=0.01] respectively)  
Conclusion: HIV positive patients had cardiac surgical outcomes with low mortality 
rates comparable to international trends which were independent of CD4 counts. 
 




















Prior to the rollout of antiretroviral therapy (ART) in South Africa, patients infected with 
human immunodeficiency virus (HIV) were frequently denied cardiac surgery because 
of concerns about short-term complications, peri-operative infection and the potential 
risk of infecting healthcare workers. 14, 17 This is despite the lack of evidence to support 
the perceived presence of increased perioperative mortality or excess risk to health care 
professionals.18 The widespread access to ART since 2003, has resulted in significant 
gains in the adult life expectancy of people living with HIV (PLHIV). Amongst patients 
starting ART with CD4 T lymphocyte (CD4 count) more than 200 cells/µl, the estimated 
life expectancy now approaches that of aged matched controls in the general 
population.19, 20 As such PLHIV currently have equal access to cardiac surgery but little 
has been published on their outcome. This is especially important in Africa with the 
highest burden of disease.  
 
PLHIV may present with a wide spectrum of heart disease which requires cardiac 
surgical interventions. HIV increases the risk of some but not all these cardiovascular 
disorders. For example, ART-naïve HIV positive patients have been shown to have an 
increased risk of myocardial infarction as a result of increased endothelial activation, 
associated with a pro-inflammatory state and elevated markers of thrombosis. In 
addition, protease inhibitors may increase the risk of coronary disease as a result of 
dyslipidemia and other metabolic derangement associated with a clinical phenotype of 
lipodystrophy.4, 21-23 Furthermore, with increasing life expectancy as a result ART, an 
increase in the prevalence of traditional risk factors such as hypertension, diabetes and 
obesity amongst ART treated HIV positive patients is well described.24  
 
Tuberculosis (TB) is responsible for 86% to 100% of pericardial disease in PLHIV and 
HIV significantly increases the risk of pericarditis. For those with TB pericarditis who 
progress to develop constrictive pericarditis, the definitive treatment is 
pericardiectomy.16, 25  In rheumatic heart disease (RHD) endemic areas of the world, the 
incidence and prevalence of valvular heart disease and its complications are presumed 
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to be similar in HIV infected and uninfected hosts, and therefore the need for valve 
replacement surgery would be similar. Finally, there is also no reason to suspect that 
the prevalence of undiagnosed congenital heart disease requiring corrective surgery (an 
important problem in HIV endemic areas such as sub-Saharan Africa) should be any 
different between PLHIV and uninfected individuals.   
 
Despite the widespread literature on the perioperative outcomes of HIV-positive patients 
in cardiac and non-cardiac procedures, little is known about HIV associated cardiac 
surgery particularly in HIV endemic areas.18, 26, 27 In North American and European 
studies of patients undergoing cardiac surgery the mortality was shown to range 
between 0 and 23% with most deaths occurring in those patients operated for infective 
endocarditis (IE).2, 7-9 There is paucity of contemporary ART era data from sub-Saharan 
Africa (SSA) on the experience and outcomes of cardiac surgery in this important 
population. We undertook this single center retrospective study to address this 
important information gap.   
 
PATIENTS AND METHODS 
 
This was a retrospective observational study conducted following approval by the 
Research Ethics committee of the Faculty of Health Sciences of the University of Cape 
Town (HREC REF: 477/2016). Patients folder numbers were obtained from a surgical 
database (HREC REF: R044/2016) at the Chris Barnard Division of Cardiothoracic 
Surgery, Groote Schuur Hospital, South Africa between 2003 and 2013. Folder numbers 
were cross referenced against the National Health Laboratory Services to identify HIV 
positive patients. For each patient who met inclusion criteria, information on 
demographics, comorbidity, special investigations, clinical parameters including New 
York Heart Association (NYHA) level of dyspnea and outcomes were captured. Relevant 
data was collected from the medical records into a pre-specified datasheet and 
transferred onto REDCap data management tool. Only complete records were considered 






The primary outcomes of interest included in-patient mortality and 30 day morbidity. 
The secondary outcomes included NYHA functional class at 30 days’ follow-up, length 
of stay and causes of death.  
  
Covariables  
Other clinical variables collected included preoperative NYHA functional class, 
anthropometry, echocardiographic findings, and patient ART history.  Surgical 
procedures were categorized as coronary artery bypass graft (CABG), valve repair or 
replacement, aortic root repair or replacement, or a combination of these and 
pericardiectomy. Other cardiac procedures included were repairs of congenital lesions. 
 
Statistical analysis 
All statistical analyses were performed using Stata/SE 15.1. Statistical tests were 
performed according to whether the variable is continuous or categorical. Continuous 
data were expressed as mean values ± SD or median values (IQR) depending on the 
normality of data. Categorical data comparisons were performed with χ2 or Fisher exact 
test were used to test for a statistical difference between variables. To further study 
associations we performed stepwise multivariate analysis using logistic regression for 






A total of 3395 patients were recorded to have been operated in the period of the study, 
and of those, 109 were confirmed HIV positive. Complete medical records of 81 
participants were obtained and captured for analysis.  
 
Figure 1. Flow diagram showing patient inclusion 
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The median CD4 count was 426.5 cells/µL (126-1402); thirty-three (40.7%) patients 
were on ART perioperatively with 25 (30.9%) patients having had the acquired 
immunodeficiency syndrome (AIDS) defining conditions (e.g. TB and pneumocystis 
jiroveii pneumonia (PJP)) previously. Only one patient was HIV and hepatitis B co-
infected. The patients were predominantly black (n=67; 82.7%), median age 34.3±10.9 
and female (n=59; 72.8%) as listed in Table 1. The majority of patients were considered 
to be normal weight for height (n=40; 55.6%) with just over a quarter in the overweight 
category (n=20; 27.8%). Only one patient had chronic kidney disease with eGFR <30; 
the median haemoglobin was 11.8±2.2; INR 1.3±0.36; creatinine 74±36.3.  
 
Table 1. Demographic characteristics and special investigation 
 
The comorbid conditions are shown in Table 2.  
A majority of the patients were in heart failure (n=65; 80.2%) at the time of surgery and 
documented RHD was present in 41 (50.6%) patients. The disease process was 
complicated by atrial fibrillation (n=17; 21%) in a subset of patients; pulmonary 
hypertension in 25 (30.9%) while 13 (16%) patients were smokers. Nine (11.1%) 
patients were diagnosed with IE in the perioperative period with 6 (7.4%) having had a 
distant history of previous IE. Of the 3 (3.7%) patients with previous ST elevation 
myocardial infarction, one was as result of vegetation embolus to epicardial coronary 
vessels. Tuberculosis (n = 23; 28.4%) was the most common opportunistic infection 
previously documented, also representing the only cause of constrictive pericarditis 
requiring pericardiectomy in this population.  
 
Table 2. Preoperative comorbidities 
 
There were 24 (29.6%) patients with severe aortic regurgitation on echocardiographic 
examination, 13 (16%) patients had severe mitral stenosis, 18 (22.2%) patients had 
severe mitral regurgitation, and the mean left ventricular ejection fraction was 54.3±12. 
Twenty (24.7%) patients required urgent surgery while emergency surgery was done in 
3 (3.7%). All emergency surgeries were redo MVR for stuck valve prosthesis; there 
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were 7 (8.6%) patients with prosthesis thrombosis, all secondary to anticoagulation non-
compliance. 
The mean Euroscore was 3.6±4.6. The distribution of surgeries performed are shown in 
Figure 2 below. The majority of patients had valve replacement; ten (12.4%) patients 
had pericardiectomy, while AVR (n= 17; 21%) was the most predominant valve surgery 
done; of the AVR patients 15 (88.2%) had mechanical prosthesis and 2 (11.8%) had 
bioprosthesis. Sixteen (19.8%) patients had MVR; mechanical prosthesis (n=14; 87.5%) 
and bioprosthesis (n= 2; 12.5%). Twelve (14.8%) patients had double valve 
replacements. Only 4 (4.9%) had CABG, of these 2 (2.5%) for were atherosclerosis 
related coronary artery disease.  
 
Figure 2: Type of surgery performed 
 
Findings 
The outcomes of HIV positive patients undergoing cardiac surgery are presented in 
Table 3.  
A total of 5 (6.2%) patients died in-hospital postoperatively with no intraoperative 
deaths. The 30 day post-operative morbidity rate was 23.5%. The recorded morbidities 
included the need for blood transfusion (n=16; 19.8%), bleeding (n=14; 17.3%), sternal 
wound sepsis (n=9; 11.1%), pleural effusions (n=7; 9%), atelectasis (n=5; 6.2%) and 
complete heart block (n=5; 6.2%). Two (2.5%) patients required repeat surgery, one 
thoracotomy for a clotted haemothorax, another had sternotomy for ongoing bleeding 
and blood loss. Three patients (3.7%) had a postoperative cardiac tamponade requiring 
drainage via a subxiphoid window.  
 
With regards to the secondary outcomes, freedom from dyspnea at 30 days was seen in 
61 (87.1%) patients at NYHA class I (n=5; 6.2% at baseline), 9 (12.9%) patients at 
NYHA class II (n=23; 28.4% at baseline) and no patient remained at NYHA class III 
(n=36; 44.4% at baseline) and NYHA class IV (n=17; 21% at baseline). Patients with 
advanced heart failure (NYHA class III/IV) preoperatively attained significant freedom 
from dyspnea at 30-days of follow-up (p <0.001). The median length of stay was 25.8 
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days and the main causes of death were mainly cardiac failure in 2 (2.5%) patients and 
sepsis in 3 (3.7%) patients.  
 
Of the participants who died from sepsis one was operated electively for H. Influenzae 
endocarditis and demised following prolonged ischemia for a combined aortic root 
replacement, MVR and CABG; this patient had extensive subacute bacterial 
endocarditis involving coronary ostia. The second patient developed S. Aureus sepsis 
following urgent aortic root reconstruction, and the third following urgent AVR for 
endocarditis. Cardiac failure was implicated in a patient with post cardiotomy low 
cardiac output syndrome who required intra-aortic balloon pump with high dose 
ionotropic support. There was no in-hospital mortality in patients undergoing 
pericardiectomy.  
 
By univariate analysis the following variables were associated with in-hospital mortality: 
aortic root replacement, redo AVR, culture positive endocarditis and atrial flutter. 
Multivariate analysis showed that cardiopulmonary bypass duration (OR 1.02 CI 1-1.04; 
p 0.01) and aortic root replacement surgery (OR 25 CI 2.5-239; p 0.006) were predictive 
of in-hospital mortality. There was no association between CD4 count and in-patient 
mortality. 
 
We did not find any association between CD4 count and the occurrence of any 
complications. Aortic root disease and prolonged hospital stay were associated with 
bleeding while aortic valve disease, acute kidney injury and prolonged hospital stay 
were associated with increased risk of the need for blood transfusions; patients with 
previous cardiac surgery, redo AVR, prolonged hospital stay and male sex were likely to 
develop acute kidney injury. There was only one (1.2%) reported needle-stick injury to 
the operating surgeon. There were no reported thromboembolic disease or urinary tract 
infections. No patient required pre or postoperative dialysis. The loss to follow-up rate 
was 7.4% with 5.3% of those patients included into those that were transferred to their 











This study investigated the 30-day survival and morbid outcomes of HIV positive 
patients undergoing cardiac surgery. The main findings were that the 30-day post-
operative mortality was 6.2% and the perioperative complication rate was 23.5%. Other 
important findings included that the vast majority of patients obtained relief from 
dyspnea at 30 days.   
The first study of this kind in SSA reported by Blyth et al described hospital mortality 
and complications rates of 6% and 34.7% respectively for HIV positive patients.14 In the 
same centre as Blyth, a smaller subgroup of HIV positive patients were found to have a 
mortality of 23% over a 3 year period, however no early mortality.15 Although the current 
complication rate is lower than previously described, we had expected an even lower 
figure given advances in general medical and surgical care as well as use of ART. 
Nevertheless, we did not find any relationship between any of the outcomes and CD4 
count; this resonates with previous literature describing similar outcomes in HIV positive 
and non-HIV positive patients regardless of the site of surgery, except anorectal 
surgery.27  
 
Previous studies have shown that a history of stroke, diabetes mellitus, congestive heart 
failure, impaired left ventricular function, previous cardiac surgery, age and beta blocker 
use were common in those with major morbidity and operative mortality. This was not 
evident in this current study and may be partly explained by the younger patient 
population (mean age less than 40) and the absence of major comorbidities. In addition, 
high preoperative creatinine, a lower eGFR, a longer cardiopulmonary bypass duration, 
longer cross-clamping and longer hospitalization stay contribute to morbidity and 
mortality.10, 28 In this study we found that a cardiopulmonary bypass duration and aortic 
root replacement were statistically significantly associated with in-hospital mortality.  
 
There was no intra or postoperative mortality in patients undergoing pericardiectomy.  
Several recent studies found a pericardiectomy mortality rates of 14-17.6%.11, 16 Only 
12.3% of our cohort underwent pericardiectomy despite a high burden of TB pericarditis, 
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an observation that may be related to the lower incidence of pericardial constriction 
previously described in HIV positive patients.29 
 
Less than 50% of patients were on ART in this cohort. This may partly be explained by 
the national treatment policy up to 2010 was that patients were only eligible for 
treatment once CD4 count fell below 200 cells/µl or patient had clinical stage IV as 
defined by the World Health Organization (DoH 2003).30 The  median CD4 count was 
426.5 cells/µl whether this reflects previous practice of only selecting patients with an 
absolute CD4 cell count above 400 cells/µL for elective cardiac surgery14 or is a 
coincidental finding is not known. Our study overlapped with a  period of concerted 
effort to increase countrywide rollout of ART in South Africa as evidence by  a 
significant jump in ART coverage from 47500 in 2004 to 1.79 million in 2011.31  
 
Only 5% of patients undergoing surgery had a CABG; a small minority of the patients 
had traditional risk factors for atherosclerosis and only 4% of the cohort were on a PI. 
First-line ART regimens in South Africa over the period of the study were nucleoside 
reverse transcriptase and non-nucleoside reverse transcriptase inhibitors based32 
explaining why so few were using PIs.   
 
RHD was the most common cause for valvular heart disease (51%). The prevalence of 
RHD in South Africa has previously been reported to be 20.2 cases per 1000 children 
based on single study.33 Infective endocarditis was the indication for surgery in 18.5% of 
patients. Koegelenberg et al did not find HIV to be a risk factor for IE in the Western 
Cape.34 In the patients with active endocarditis, 3.7% were culture positive while 7% 
were culture negative. The incidence of culture negative endocarditis may reflect 
antibiotic administration prior to sampling of blood cultures as this is the most common 
cause of culture negative endocarditis.15, 35 
 
The majority of patients with valve replacement surgery received mechanical valves for 
both mitral and aortic prosthesis; these patients were younger than 60 years of age as 
per European Society of Cardiology guidelines.36 Although mechanical valves offer 
13 
 
longer durability, they are associated with anticoagulation-related bleeding and 
thromboembolism. All emergency surgeries done in this cohort were for stuck valves 
related to warfarin non-compliance. In addition, the median length of stay was 25.8 days 
with time to therapeutic international normalized ratio (INR) for warfarin a major 
contributor while in those patients with endocarditis, antibiotics duration before surgery 
was another contributor.  
 
In conclusion, this retrospective single center study suggests that in an era in which the 
population coverage of ART amongst HIV infected patients is approximately 50%, the 
perioperative mortality and morbidity is in line with what has been described in other 
parts of the globe but has changed little over the last decade in South Africa. The data 
suggests that over the period covered by the review few patients with advanced HIV 
were being selected for cardiac surgery.  
 
Our study has several limitations, firstly this is a single centre experience and cannot be 
generalized to the heterogenous practice in the resource limited sub-Saharan region. 
Secondly, the retrospective nature of the study made it difficult to find all patients with 
complete data reducing the study population and ability to study certain associations. 
Third, we did not have a control group to make comparisons to HIV uninfected 
population. Lastly, this patient population may represent a carefully selected HIV 
positive patient undergoing cardiac surgery as determined by previous practices 




We thank the Groote Schuur Hospital Medical Records department for the continued 









1. Shisana O, Rehle T, Simbayi LC, Zuma K, Jooste S, Zungu N, Labadarios D and Onoya D. 
South African national HIV prevalence, incidence and behaviour survey, 2012. 2014. 
2. Boccara F, Cohen A, Di Angelantonio E, Meuleman C, Ederhy S, Dufaitre G, Odi G, Teiger 
E, Barbarini G and Barbaro G. Coronary artery bypass graft in HIV-infected patients: a 
multicenter case control study. Current HIV research. 2008;6:59-64. 
3. Friis-Moller N, Reiss P, Sabin CA, Weber R, Monforte A, El-Sadr W, Thiebaut R, De Wit S, 
Kirk O, Fontas E, Law MG, Phillips A and Lundgren JD. Class of antiretroviral drugs and the risk of 
myocardial infarction. The New England journal of medicine. 2007;356:1723-35. 
4. Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M and Stewart S. Contribution 
of the human immunodeficiency virus/acquired immunodeficiency syndrome epidemic to de 
novo presentations of heart disease in the Heart of Soweto Study cohort. European heart 
journal. 2012;33:866-74. 
5. Thienemann F, Sliwa K and Rockstroh JK. HIV and the heart: the impact of antiretroviral 
therapy: a global perspective. European heart journal. 2013;34:3538-46. 
6. Funderburg NT. Markers of coagulation and inflammation often remain elevated in ART-
treated HIV-infected patients. Curr Opin HIV AIDS. 2014;9:80-6. 
7. Trachiotis GD, Alexander EP, Benator D and Gharagozloo F. Cardiac surgery in patients 
infected with the human immunodeficiency virus. The Annals of thoracic surgery. 
2003;76:1114-8; discussion 1118. 
8. Mestres CA, Chuquiure JE, Claramonte X, Munoz J, Benito N, Castro MA, Pomar JL and 
Miro JM. Long-term results after cardiac surgery in patients infected with the human 
immunodeficiency virus type-1 (HIV-1). European journal of cardio-thoracic surgery : official 
journal of the European Association for Cardio-thoracic Surgery. 2003;23:1007-16; discussion 
1016. 
9. Chong T, Alejo DE, Greene PS, Redmond JM, Sussman MS, Baumgartner WA and 
Cameron DE. Cardiac valve replacement in human immunodeficiency virus-infected patients. 
The Annals of thoracic surgery. 2003;76:478-80; discussion 480-1. 
10. Polanco A, Itagaki S, Chiang Y and Chikwe J. Changing prevalence, profile, and outcomes 
of patients with HIV undergoing cardiac surgery in the United States. American heart journal. 
2014;167:363-8. 
11. Robich MP, Schiltz N, Johnston DR, Mick S, Tse W, Koch C and Soltesz EG. Outcomes of 
patients with human immunodeficiency virus infection undergoing cardiovascular surgery in the 
United States. The Journal of thoracic and cardiovascular surgery. 2014;148:3066-73. 
12. Filsoufi F, Salzberg SP, Harbou KT, Neibart E and Adams DH. Excellent outcomes of 
cardiac surgery in patients infected with HIV in the current era. Clin Infect Dis. 2006;43:532-6. 
13. Castillo JG, Adams DH, Rahmanian PB and Filsoufi F. [Cardiovascular surgery in patients 
with HIV: epidemiology, current indications, and long-term outcome]. Rev Esp Cardiol. 
2008;61:480-6. 
14. Blyth DF, Buckels NJ, Sewsunker RR, Khan S and Mathivha TM. An experience with 
cardiopulmonary bypass in HIV-infected patients. Cardiovascular journal of South Africa : 
15 
 
official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac 
Practitioners. 2006;17:178-85. 
15. Nel SH and Naidoo DP. An echocardiographic study of infective endocarditis, with 
special reference to patients with HIV. Cardiovasc J Afr. 2014;25:50-7. 
16. Mutyaba AK, Balkaran S, Cloete R, du Plessis N, Badri M, Brink J and Mayosi BM. 
Constrictive pericarditis requiring pericardiectomy at Groote Schuur Hospital, Cape Town, South 
Africa: causes and perioperative outcomes in the HIV era (1990-2012). The Journal of thoracic 
and cardiovascular surgery. 2014;148:3058-65.e1. 
17. Clement ME, Lin L, Navar AM, Okeke NL, Naggie S and Douglas PS. Lower likelihood of 
cardiac procedures after acute coronary syndrome in patients with human immunodeficiency 
virus/acquired immunodeficiency syndrome. Medicine (Baltimore). 2018;97:e9849. 
18. Moodley Y and Govender K. An HIV-positive status and short term perioperative 
mortality – a systematic review. Southern African Journal of Infectious Diseases. 2017;32:12-16. 
19. Bor J, Herbst AJ, Newell ML and Barnighausen T. Increases in adult life expectancy in 
rural South Africa: valuing the scale-up of HIV treatment. Science (New York, NY). 2013;339:961-
5. 
20. Johnson LF, Mossong J, Dorrington RE, Schomaker M, Hoffmann CJ, Keiser O, Fox MP, 
Wood R, Prozesky H, Giddy J, Garone DB, Cornell M, Egger M and Boulle A. Life expectancies of 
South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. 
PLoS medicine. 2013;10:e1001418. 
21. Mooser V. Atherosclerosis and HIV in the highly active antiretroviral therapy era: 
towards an epidemic of cardiovascular disease? AIDS (London, England). 2003;17 Suppl 1:S65-9. 
22. Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte AD, 
Friis-Moller N, Kirk O, Fontas E, Weller I, Phillips A and Lundgren J. Risk of myocardial infarction 
in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 
major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. The 
Journal of infectious diseases. 2010;201:318-30. 
23. Vachiat A, McCutcheon K, Tsabedze N, Zachariah D and Manga P. HIV and Ischemic 
Heart Disease. J Am Coll Cardiol. 2017;69:73-82. 
24. Hontelez JA, de Vlas SJ, Baltussen R, Newell ML, Bakker R, Tanser F, Lurie M and 
Barnighausen T. The impact of antiretroviral treatment on the age composition of the HIV 
epidemic in sub-Saharan Africa. AIDS (London, England). 2012;26 Suppl 1:S19-30. 
25. Ntsekhe M and Hakim J. Impact of human immunodeficiency virus infection on 
cardiovascular disease in Africa. Circulation. 2005;112:3602-7. 
26. Redman LA, Naidoo P and Biccard BM. HIV, vascular surgery and cardiovascular 
outcomes: a South African cohort study. Anaesthesia. 2014;69:208-13. 
27. Madiba TE, Muckart DJ and Thomson SR. Human immunodeficiency disease: how should 
it affect surgical decision making? World journal of surgery. 2009;33:899-909. 
28. Ono M, Brady K, Easley RB, Brown C, Kraut M, Gottesman RF and Hogue CW, Jr. 
Duration and magnitude of blood pressure below cerebral autoregulation threshold during 
cardiopulmonary bypass is associated with major morbidity and operative mortality. The 
Journal of thoracic and cardiovascular surgery. 2014;147:483-9. 
16 
 
29. Ntsekhe M, Wiysonge CS, Gumedze F, Maartens G, Commerford PJ, Volmink JA and 
Mayosi BM. HIV infection is associated with a lower incidence of constriction in presumed 
tuberculous pericarditis: a prospective observational study. PLoS One. 2008;3:e2253. 
30. Health Do. Operational plan for comprehensive HIV and AIDS care, management and 
treatment for South Africa. 
Available:http://www.info.gov.za/otherdocs/2003/aidsplan/report.pdf. 2003. 
31. Johnson LF. Access to antiretroviral treatment in South Africa, 2004 - 2011. 2012. 
2012;13:6. 
32. Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, 
Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F and Venter F. Adult 
antiretroviral therapy guidelines 2017. 2017. 2017;18. 
33. Zuhlke LJ, Engel ME, Watkins D and Mayosi BM. Incidence, prevalence and outcome of 
rheumatic heart disease in South Africa: a systematic review of contemporary studies. 
International journal of cardiology. 2015;199:375-83. 
34. Koegelenberg CF, Doubell AF, Orth H and Reuter H. Infective endocarditis in the 
Western Cape Province of South Africa: a three-year prospective study. QJM : monthly journal 
of the Association of Physicians. 2003;96:217-25. 
35. Hitzeroth J, Beckett N and Ntuli P. An approach to a patient with infective endocarditis; 
2015. 
36. Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, 
Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, 
Wendler O, Windecker S, Zamorano JL and Group ESCSD. 2017 ESC/EACTS Guidelines for the 








































FIGURES AND TABLES 
 
 












Characteristic  HIV n=81, (%) 
Median age , y ± SD 34.3 ± 10.9 
Age group  
0-29 28 (35) 
30-39 31 (38) 
40-59 21 (26) 
Female  59 (72.8) 
Anthropometry  
Normal 40 (55.6) 
Overweight 20 (27.8) 
Race   
Black  67 (82.7) 
Colored  11 (13.9) 
White  3 (3.7) 
Special 
investigations 
Median ± SD (min-
max) 
Haemoglobin  11.8 ±2.2 (7-19) 
Creatinine  74 ± 36.3 (43-286) 
eGFR 106.1 ± 25.6 (21-130) 
INR 1.3 ± 0.36 (1-3.3) 
LVEF by 
echocardiogram 













































Table 2. Pre-operative comorbidities 
Characteristics HIV n = 81, (%) 
Hypertension 6 (7.4) 
Heart Failure 65 (80.2) 
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Diabetes Mellitus 1 (1.2) 
Rheumatic heart disease 41 (50.6) 
Previous Stroke 5 (6.2) 
Smoking 13 (16) 
Chronic kidney disease 1 (1.2) 
Cardiomyopathy 2 (2.5) 
Previous Tuberculosis 23 (28.4) 
COPD 4 (4.9) 
Previous Endocarditis 6 (7.4) 
Active endocarditis 9 (11.1) 
Previous PCP 1 (1.2) 
Dyslipidaemia 3 (3.7) 
Unstable angina 2 (2.5) 
NSTEMI 2 (2.5) 
STEMI 3 (3.7) 
Hepatits B 1 (1.2) 
Congenital Aortic Disease 2 (2.5) 
Degenerative AV disease 2 (2.5) 
Atrial fibrillation 17 (21) 

















Table 3. Post-operative outcomes 
Event  n(%) 
Hospital mortality n, % 5 (6.2) 
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Functional class at 30 days n, %   
New York Heart Association I 61 (87) 
New York Heart Association II 9 (12.8) 
Complications n, % 19 (23.5)  
Wound sepsis  9 (11.1) 
Pneumonia 3 (3.7) 
Complete heart block 5 (6.2) 
Bleeding 14 (17.3) 
Acute kidney injury 4 (4.9) 
Haemothorax 1 (1.2) 
Atelectasis 5 (6.2) 
Stroke  1 (1.2) 
Pleural effusion  7 (8.6) 
Atrial fibrillation  1 (1.2) 
Atrial flutter 2 (2.5) 
Cardiac tamponade 3 (3.7) 
Repeat thoracotomy 2 (2.5) 
Blood transfusion 16 (19.8) 
Pneumothorax 1 (1.2) 
Pneumopericardium 1 (1.2) 
Needle-stick injury 1 (1.2) 
Discharge disposition, n (%)   
Home 72 (94.7) 
Transfer base hospital 4 (5.3) 
Length of hospital stay, median d 25.8 (6-116)  
30 days’ follow-up n, %   
Alive 70 (86.4) 
Died 5 (6.2) 
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Mortality and surgery 
 

























AVR Redo AVR MVR Redo MVR Aotic root
replacement
TV repair
Type of surgery and mortality 
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Appendix 2. Additional tables 
Column1 
Column1 
Effect of CD4 count on mortality 
 
Median CD4 count - Alive 428 (272 - 
628) 
Median CD4 count - Dead 519 (300 - 
659) 
Median CD4 count - LTFU 413 (401 - 
480) 
 
CD4 count appears to be higher in those who die compared to the 




HIV immune status 
  
Median CD4 count (15th, 85th percentiles) 426.5 (272, 
628) 
ART preoperative  33 (40.74) 
NRTI 33 (40.74) 
NNRTI 33 (40.74) 
PI 3 (3.7) 




Level of dyspnea 
Proportion with NYHA III/IV pre-op 53 (65.4) 
Proportion with NYHA I at 30 days 35 (66.0) 

















Mean +- SD 3.58 +-4.63 
Min 0,5 
Max 25,71 
AVR n, %   
Bioprosthetic 2 (2.47) 
Mechanical 15 (18.52) 
MVR n, %   
Bioprosthetic 2 (2.47) 
Metallic 14 (17.28) 
TV repair n, % 11 (13.58)  
Aortic root replacement 
n, % 
4 (4.94) 
Aortic root repair n, % 3 (3.7) 
CABG 1 n, % 1 (1.23) 
CABG 3 n, % 2 (2.47) 
CABG 4 n, % 1 (1.23) 
ASD repair  5 (6.17) 
Pericardectomy 10 (12.35)  
MAZE procedure 4 (4.94) 
TOF repair 2 (2.47) 
Redo-MVR 7 (8.64) 
Redo-AVR 2 (2.47) 
DVR 12 (14.81) 
MV repair 6 (7.41) 
Emergency surgery 3 (3.7) 
Urgent surgery 20 (24.69) 
Aortic clamp time   











Appendix 3. Data collection sheet 
 
The impact of HIV on one-month survival amongst patients undergoing cardiac surgery at Groote Schuur Hospital in the 
ART era 
Demographics 
 Surname  
 First name  
 Date of birth (dd-mm-yyyy)  
Sex Male Female 
Race if available  African Black Colored/mixed-
ancestry 
White Indian/Asian Other 
Immune status 
 HIV Status Positive Negative 
Year of diagnosis  Prev. AIDS-defining 
condition 







Y N NRTI NNRTI PI Other 
Time on ART <3 mo 3-6 mo 6-12 mo >12 mo   
Compliance on history  Yes  No      
 
Comorbidities  
 HPT Diabetes Mellitus Insulin use Previous  stroke Smoking  COPD 
CKD Rheumatic Fever Cardiomyopathy Atrial fibrillation  Previous Tuberculosis 
Asthma Anaemia Peripheral vascular disease  Chronic lung disease 
Recent MI (90 days) Rheumatic heart disease Heart failure Dyslipidemia Unstable Angina Stable Angina 
Prev. NSTEMI  Prev. STEMI Liver Disease Pulmonary 
hypertensio
n 







Lymphoma Prev. cancer Large vessel 
vasculitis  
Biochemical  
 Hb  Creatinine  eGFR  Triglyceride  Cholesterol  LDL  
HDL  INR  Tot. 
Bili 
 Albumin       
Cardiac status pre-op 








 Mitral valve 
disease 








Angioplasty Prev. DES Prev. 
BMS 




NYHA I NYHA II NYHA III NYHA IV CCS I CCS II CCS III CCS IV 
Weight (kg)  Height (cm)  BMI  mPAP 
(mmHg) 
 
Mitral regurgitation Trivial  Mild  Moderate Severe  
30 
 
Aortic regurgitation Trivial  Mild  Moderate Severe  
Tricuspid regurgitation  Trivial  Mild  Moderate Severe  
Mitral stenosis Trivial Mild Moderate Severe  
Aortic stenosis Trivial Mild Moderate Severe  
Ionotropic support Ventilation Dialysis IABP ICU admission 
Active Endocarditis Culture positive Culture negative  
Organism   Aortic disease   
Perioperative  









CABG 4 Emergency surgery 
CABG 1 CABG 2 CABG 3 Urgent surgery Elective surgery Mechanical  valve 
Bioprosthetic 
valve 
Aortic Clamp time (min)   Cardiopulmonary 
bypass (min) 
 Pericardectomy  
Re-do MVR Re-do AVR TOF repair     
Year of surgery  EuroScore II  STS score   
Postoperative morbidity  
 Sternal wound 
sepsis 
HAP Mediastinitis  UTI Complete Heart Block Tamponade Bleeding  















Coagulopathy  IABP LVAD use Pneumopericardium  Pneumothorax    
Mortality and follow-up 
 Total hospital stay (days)  Hospital stay post-op   
 Date of admission   Date of death    
Discharge disposition Home Inpatient care Transfer base hospital 
Follow-up disposition at 30 days Alive Dead Loss to follow-up Hospitalized  
NYHA at 30 days NYHA I NYHA II NYHA III NYHA IV 
CCS at 30 days CCS I CCS II CCS III CCS IV 
Time from surgery to death (days)    
Cause of Death       
 
 
 
 
 
 
 
